Business ❯ Finance ❯ Market Analysis ❯ Analyst Ratings

Investment Strategies

Moderna Repositions as Broad mRNA Company After Investor Day Rally

The company has laid out a three‑horizon pipeline and commercial plan that could translate into multiple vaccine and oncology launches and near‑term regulatory catalysts.

3 ARTICLES

last mo.

Kyndryl Delays 10-Q and Launches Controls Review After SEC Requests as Finance and Legal Chiefs Exit

39 ARTICLES

8mo ago

Circle Posts $214 Million Q3 Profit on USDC Surge as Stock Falls on Rate, Cost Jitters

8 ARTICLES

last yr.

Gap's Early Q2 Results Reveal Strong Sales Growth

Investment Strategies

Moderna Repositions as Broad mRNA Company After Investor Day Rally

EA Stock Hits Record High as $55 Billion Take‑Private Deal Remains Pending

Shopify’s Stock Lags as AI Commerce Accelerates

Nebius Sets New High on $643 Million Eigen AI Deal

Analysts Back Meta Before Q1 Despite Surging AI Spend

SoFi–Muddy Waters Clash Deepens as Shares Swing

Kyndryl Delays 10-Q and Launches Controls Review After SEC Requests as Finance and Legal Chiefs Exit

Circle Posts $214 Million Q3 Profit on USDC Surge as Stock Falls on Rate, Cost Jitters

Gap's Early Q2 Results Reveal Strong Sales Growth